Faculty

Back to Index
Min Janice Lu, MD, PhD
Clinical Professor of Medicine (Clinician Educator)
Medicine
HCT 1520 San Pablo St Health Sciences Campus Los Angeles
+1 323 865 0314

Overview

Dr. Janice Lu is a clinical professor of medicine in the division of medical oncology at the USC Norris Comprehensive Cancer Center. Dr. Lu is certified by the American Board of Internal Medicine and Medical Oncology. She is also a member of the American Society of Clinical Oncology.

She has extensive experience in clinical trials, breast cancer drug development and has led studies as national protocol chair. She serves as associate director of breast cancer research and director of breast cancer clinical trials at USC Norris Cancer Center.

Dr. Lu completed her Hematology and Medical Oncology fellowship at New York University School of Medicine. She earned her PhD degree in Molecular Biology with Dr. David Allis, a pioneer in the foundations of epigenetics at Rockefeller University. Prior to joining to USC Norris Cancer Center, she served as an Associate Professor of Clinical Medicine in the Division of Hematology and Oncology at UCLA. Dr. Lu also served as the Director of the Breast Medical Oncology Program at SUNY Stony Brook for eight years.

Dr. Lu’s career has focused on the management of women with breast cancer in which she excels with her expertise and warm and caring nature. She is dedicated to the cancer community and serves as a board member for the Cancer Support Community in Santa Monica. Her goal is to utilize her science and medical knowledge to work with each patient on a highly individualized basis with state-of-the-art cancer care.

Awards

New York University Cancer Center: Translational Research Task Force Award, 2003

Syracuse University: All-University Doctoral Prize, 1995

Biannual Ovarian Cancer Research Symposium: Hematology/Oncology Fellows Award, 2002

SUNY at Stony Brook School of Medicine: Carol M. Baldwin Breast Cancer Research Award, 2005

SUNY at Stony Brook School of Medicine: Maffetone Award for Fighting Breast Cancer, 2010

SUNY at Stony Brook School of Medicine: award or honor for, 2005

Biannual Ovarian Cancer Research Symposium: award or honor for, 2002

Syracuse University: award or honor for, 1995

New York University Cancer Center: award or honor for, 2003

SUNY at Stony Brook School of Medicine: full name, 2005

New York University Cancer Center: full name, 2003

Syracuse University: full name, 1995

Biannual Ovarian Cancer Research Symposium: full name, 2002

Syracuse University: person in primary position, 1995

SUNY at Stony Brook School of Medicine: person in primary position, 2005

SUNY at Stony Brook School of Medicine: person in primary position, 2010

Biannual Ovarian Cancer Research Symposium: person in primary position, 2002

New York University Cancer Center: person in primary position, 2003

Biannual Ovarian Cancer Research Symposium: last name, 2002

SUNY at Stony Brook School of Medicine: last name, 2010

New York University Cancer Center: last name, 2003

Syracuse University: last name, 1995

SUNY at Stony Brook School of Medicine: last name, 2005

New York University Cancer Center: HR job title, 2003

SUNY at Stony Brook School of Medicine: HR job title, 2005

Biannual Ovarian Cancer Research Symposium: HR job title, 2002

Syracuse University: HR job title, 1995

SUNY at Stony Brook School of Medicine: HR job title, 2010

SUNY at Stony Brook School of Medicine: full name, 2010

New York University Cancer Center: position in department, 2003

SUNY at Stony Brook School of Medicine: position in department, 2010

SUNY at Stony Brook School of Medicine: position in department, 2005

Syracuse University: position in department, 1995

Biannual Ovarian Cancer Research Symposium: position in department, 2002

Syracuse University: sort order, 1995

Biannual Ovarian Cancer Research Symposium: sort order, 2002

SUNY at Stony Brook School of Medicine: sort order, 2010

New York University Cancer Center: sort order, 2003

SUNY at Stony Brook School of Medicine: sort order, 2005

Biannual Ovarian Cancer Research Symposium: Organization, 2002

Syracuse University: Organization, 1995

SUNY at Stony Brook School of Medicine: Organization, 2005

SUNY at Stony Brook School of Medicine: Organization, 2010

New York University Cancer Center: Organization, 2003

Syracuse University: email address, 1995

New York University Cancer Center: email address, 2003

SUNY at Stony Brook School of Medicine: email address, 2010

Biannual Ovarian Cancer Research Symposium: email address, 2002

SUNY at Stony Brook School of Medicine: email address, 2005

SUNY at Stony Brook School of Medicine: start date, 2005

Syracuse University: start date, 1995

New York University Cancer Center: start date, 2003

Biannual Ovarian Cancer Research Symposium: start date, 2002

SUNY at Stony Brook School of Medicine: start date, 2010

SUNY at Stony Brook School of Medicine: type, 2010

Syracuse University: type, 1995

Biannual Ovarian Cancer Research Symposium: type, 2002

SUNY at Stony Brook School of Medicine: type, 2005

New York University Cancer Center: type, 2003

Syracuse University: workplace homepage, 1995

New York University Cancer Center: workplace homepage, 2003

SUNY at Stony Brook School of Medicine: workplace homepage, 2010

Biannual Ovarian Cancer Research Symposium: workplace homepage, 2002

SUNY at Stony Brook School of Medicine: workplace homepage, 2005

New York University Cancer Center: Professor, 2003

SUNY at Stony Brook School of Medicine: Professor, 2005

Syracuse University: Professor, 1995

Biannual Ovarian Cancer Research Symposium: Professor, 2002

SUNY at Stony Brook School of Medicine: Professor, 2010

Biannual Ovarian Cancer Research Symposium: award conferred by, 2002

Syracuse University: award conferred by, 1995

SUNY at Stony Brook School of Medicine: award conferred by, 2005

New York University Cancer Center: award conferred by, 2003

SUNY at Stony Brook School of Medicine: award conferred by, 2010

Biannual Ovarian Cancer Research Symposium: Faculty Rank, 2002

SUNY at Stony Brook School of Medicine: Faculty Rank, 2005

Syracuse University: Faculty Rank, 1995

SUNY at Stony Brook School of Medicine: Faculty Rank, 2010

New York University Cancer Center: Faculty Rank, 2003

SUNY at Stony Brook School of Medicine: is primary position, 2005

Syracuse University: is primary position, 1995

SUNY at Stony Brook School of Medicine: is primary position, 2010

Biannual Ovarian Cancer Research Symposium: is primary position, 2002

Syracuse University: preferred title, 1995

Biannual Ovarian Cancer Research Symposium: preferred title, 2002

SUNY at Stony Brook School of Medicine: preferred title, 2010

SUNY at Stony Brook School of Medicine: preferred title, 2005

New York University Cancer Center: Agent, 2003

Syracuse University: Agent, 1995

SUNY at Stony Brook School of Medicine: Agent, 2010

Biannual Ovarian Cancer Research Symposium: Agent, 2002

SUNY at Stony Brook School of Medicine: Agent, 2005

SUNY at Stony Brook School of Medicine: first name, 2005

Syracuse University: first name, 1995

New York University Cancer Center: first name, 2003

Biannual Ovarian Cancer Research Symposium: first name, 2002

SUNY at Stony Brook School of Medicine: first name, 2010

New York University Cancer Center: position in organization, 2003

SUNY at Stony Brook School of Medicine: position in organization, 2010

SUNY at Stony Brook School of Medicine: position in organization, 2005

Syracuse University: Person ID, 1995

Biannual Ovarian Cancer Research Symposium: Person ID, 2002

New York University Cancer Center: Person ID, 2003

SUNY at Stony Brook School of Medicine: Person ID, 2010

SUNY at Stony Brook School of Medicine: Person ID, 2005

SUNY at Stony Brook School of Medicine: has faculty rank, 2010

Syracuse University: has faculty rank, 1995

Biannual Ovarian Cancer Research Symposium: has faculty rank, 2002

New York University Cancer Center: has faculty rank, 2003

SUNY at Stony Brook School of Medicine: Lu, Min Janice, 2005

Syracuse University: Lu, Min Janice, 1995

Biannual Ovarian Cancer Research Symposium: Lu, Min Janice, 2002

New York University Cancer Center: Lu, Min Janice, 2003

SUNY at Stony Brook School of Medicine: Lu, Min Janice, 2010

Syracuse University: Medicine, 1995

SUNY at Stony Brook School of Medicine: Medicine, 2010

Biannual Ovarian Cancer Research Symposium: Medicine, 2002

SUNY at Stony Brook School of Medicine: Medicine, 2005

New York University Cancer Center: Medicine, 2003

Biannual Ovarian Cancer Research Symposium: Keck School of Medicine of USC, 2002

New York University Cancer Center: Keck School of Medicine of USC, 2003

SUNY at Stony Brook School of Medicine: Keck School of Medicine of USC, 2010

Syracuse University: Keck School of Medicine of USC, 1995

SUNY at Stony Brook School of Medicine: Keck School of Medicine of USC, 2005

New York University Cancer Center: is primary position, 2003

SUNY at Stony Brook School of Medicine: Position, 2010

Syracuse University: Position, 1995

SUNY at Stony Brook School of Medicine: Position, 2005

New York University Cancer Center: Position, 2003

Biannual Ovarian Cancer Research Symposium: Position, 2002

SUNY at Stony Brook School of Medicine: has faculty rank, 2005

Publications

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2013 Mar 20; 31(9):1157-63. View in: PubMed

Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int J Cancer. 2010 Feb 1; 126(3):669-83. View in: PubMed

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study. Gynecol Oncol. 2008 Mar; 108(3):500-4. View in: PubMed

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. Lancet Oncol. 2008 Feb; 9(2):117-23. View in: PubMed

Novel therapies in breast cancer: what is new from ASCO 2008. J Hematol Oncol. 2008; 1:16. View in: PubMed

Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy. Hematol Oncol Clin North Am. 2003 Aug; 17(4):969-75. View in: PubMed

Emerging treatments for ovarian cancer. Expert Opin Emerg Drugs. 2003 May; 8(1):203-16. View in: PubMed

Powered bySC CTSI